Key facts
- This page summarizes TardiMed Sciences LLC's Form 3 filing for PaxMedica, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Aug 2022, 18:31.
TardiMed Sciences LLC - 12 Aug 2022 Form 3 Insider Report for PaxMedica, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 12 Aug 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 12 Aug 2022, 18:31:48 UTC
- Prior SEC filing
- 02 Sep 2021
- Next SEC filing
- 01 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Derby, Managing Partner of TardiMed Sciences LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
TardiMed Sciences LLC filed Form 3 for PaxMedica, Inc. on 12 Aug 2022.
Change
- Previous filing in this sequence was filed on 02 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PXMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,241,745
- Date
- 12 Aug 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.